NCT03424707View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 4, 2016

Primary Completion Date

August 30, 2016

Study Completion Date

August 30, 2016

Conditions
Acute Low Back Pain
Interventions
DRUG

DW340(pelubiprofen/eperisone)

DW340

DRUG

Pelubi(pelubiprofen)

pelubiprofen

DRUG

Placebo Oral Tablet

Placebo Oral Tablet

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT03424707 - A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain | Biotech Hunter | Biotech Hunter